13F-HR filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-04-22, with 42 holding rows worth $1,272,571,368.
- Accession
- 0001213900-24-034979
- Filer
- CIK 1674712
- Filed
- 2024-04-22
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 42 entries on the cover page, a total value of $1,272,571,368 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,272,571,368 with VALUE read as dollars as filed, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | 834203309 | COM | 8,418,093 | $360,294,380 | dollars as filed | |
| GERON CORP | 374163103 | COM | 27,225,292 | $89,843,464 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 2,606,247 | $87,517,774 | dollars as filed | |
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 11,800,000 | $76,346,000 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 3,972,099 | $67,088,752 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,610,177 | $58,087,748 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 4,220,048 | $47,053,535 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,635,136 | $46,421,511 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 6,657,992 | $43,676,428 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 2,329,027 | $32,781,055 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,678,207 | $29,385,405 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,105,454 | $23,877,806 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,873,704 | $21,210,329 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 1,500,000 | $21,210,000 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 520,505 | $20,794,175 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 565,550 | $20,557,743 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,538,461 | $18,153,840 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 350,000 | $16,383,500 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,244,941 | $15,086,004 | dollars as filed | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 1,650,440 | $15,019,004 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 5,000,000 | $14,400,000 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 591,882 | $13,554,098 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,608,000 | $13,378,560 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 849,681 | $11,683,114 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 678,705 | $11,504,050 | dollars as filed | |
| GENETRON HLDGS LTD | 37186H209 | ADS | 2,708,056 | $10,899,925 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 6,173,439 | $10,680,049 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 2,088,323 | $10,399,849 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 531,198 | $8,509,792 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 1,666,746 | $7,950,378 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 2,797,704 | $7,134,145 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 3,556,023 | $7,040,926 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 624,338 | $6,742,850 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 370,068 | $6,305,959 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 3,521,291 | $4,929,807 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 3,470,152 | $4,788,810 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,988,000 | $3,764,880 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 3,547,030 | $3,476,089 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 2,708,875 | $2,029,218 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 388,144 | $1,354,623 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 509,572 | $1,192,398 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 4,675 | $63,395 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-24-034979 | this filing | 2024-04-22 | acceptance time not in the bulk data set |